Logo image of TECH

BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:TECH - US09073M1045 - Common Stock

59.22 USD
+0.03 (+0.05%)
Last: 12/26/2025, 8:18:04 PM
59.22 USD
0 (0%)
After Hours: 12/26/2025, 8:18:04 PM
Fundamental Rating

6

TECH gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. TECH gets an excellent profitability rating and is at the same time showing great financial health properties. TECH has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

TECH had positive earnings in the past year.
In the past year TECH had a positive cash flow from operations.
Each year in the past 5 years TECH has been profitable.
Each year in the past 5 years TECH had a positive operating cash flow.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

The Return On Assets of TECH (3.04%) is better than 73.68% of its industry peers.
With a decent Return On Equity value of 3.91%, TECH is doing good in the industry, outperforming 73.68% of the companies in the same industry.
The Return On Invested Capital of TECH (9.33%) is better than 84.21% of its industry peers.
TECH had an Average Return On Invested Capital over the past 3 years of 9.00%. This is below the industry average of 13.99%.
The 3 year average ROIC (9.00%) for TECH is below the current ROIC(9.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROIC 9.33%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 6.32%, TECH is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
TECH's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 22.13%, TECH belongs to the top of the industry, outperforming 91.23% of the companies in the same industry.
TECH's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 66.83%, TECH belongs to the best of the industry, outperforming 89.47% of the companies in the same industry.
In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
Industry RankSector Rank
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

7

2. Health

2.1 Basic Checks

TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, TECH has less shares outstanding
The number of shares outstanding for TECH has been increased compared to 5 years ago.
TECH has a worse debt/assets ratio than last year.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

TECH has an Altman-Z score of 11.53. This indicates that TECH is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 11.53, TECH belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
TECH has a debt to FCF ratio of 1.34. This is a very positive value and a sign of high solvency as it would only need 1.34 years to pay back of all of its debts.
TECH has a better Debt to FCF ratio (1.34) than 89.47% of its industry peers.
TECH has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
TECH's Debt to Equity ratio of 0.15 is in line compared to the rest of the industry. TECH outperforms 59.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Altman-Z 11.53
ROIC/WACC0.86
WACC10.79%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

TECH has a Current Ratio of 4.22. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.22, TECH is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 2.81 indicates that TECH has no problem at all paying its short term obligations.
TECH has a Quick ratio (2.81) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 4.22
Quick Ratio 2.81
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.82% over the past year.
The Earnings Per Share has been growing by 11.25% on average over the past years. This is quite good.
The Revenue for TECH has decreased by -16.00% in the past year. This is quite bad
Measured over the past years, TECH shows a quite strong growth in Revenue. The Revenue has been growing by 10.55% on average per year.
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%

3.2 Future

The Earnings Per Share is expected to grow by 8.61% on average over the next years. This is quite good.
Based on estimates for the next years, TECH will show a small growth in Revenue. The Revenue will grow by 7.10% on average per year.
EPS Next Y4.76%
EPS Next 2Y7.66%
EPS Next 3Y10.98%
EPS Next 5Y8.61%
Revenue Next Year0.56%
Revenue Next 2Y3.76%
Revenue Next 3Y6.14%
Revenue Next 5Y7.1%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

TECH is valuated quite expensively with a Price/Earnings ratio of 30.68.
70.18% of the companies in the same industry are more expensive than TECH, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.92. TECH is around the same levels.
A Price/Forward Earnings ratio of 26.47 indicates a quite expensive valuation of TECH.
Compared to the rest of the industry, the Price/Forward Earnings ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 75.44% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.46. TECH is around the same levels.
Industry RankSector Rank
PE 30.68
Fwd PE 26.47
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TECH is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TECH indicates a somewhat cheap valuation: TECH is cheaper than 64.91% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 41.18
EV/EBITDA 25
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
TECH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)6.44
PEG (5Y)2.73
EPS Next 2Y7.66%
EPS Next 3Y10.98%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.54%, TECH is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.09, TECH pays a better dividend. On top of this TECH pays more dividend than 92.98% of the companies listed in the same industry.
With a Dividend Yield of 0.54, TECH pays less dividend than the S&P500 average, which is at 2.00.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

The dividend of TECH has a limited annual growth rate of 0.11%.
TECH has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of TECH decreased recently.
Dividend Growth(5Y)0.11%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

65.26% of the earnings are spent on dividend by TECH. This is not a sustainable payout ratio.
The dividend of TECH is growing, but earnings are growing more, so the dividend growth is sustainable.
DP65.26%
EPS Next 2Y7.66%
EPS Next 3Y10.98%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (12/26/2025, 8:18:04 PM)

After market: 59.22 0 (0%)

59.22

+0.03 (+0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-05 2025-11-05/bmo
Earnings (Next)02-03 2026-02-03/bmo
Inst Owners107%
Inst Owner Change7.13%
Ins Owners0.25%
Ins Owner Change3.89%
Market Cap9.23B
Revenue(TTM)1.22B
Net Income(TTM)76.84M
Analysts81.74
Price Target71.26 (20.33%)
Short Float %5.95%
Short Ratio4.8
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.32
Dividend Growth(5Y)0.11%
DP65.26%
Div Incr Years0
Div Non Decr Years1
Ex-Date11-17 2025-11-17 (0.08)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.05%
Min EPS beat(2)-2.04%
Max EPS beat(2)4.14%
EPS beat(4)3
Avg EPS beat(4)4.01%
Min EPS beat(4)-2.04%
Max EPS beat(4)7.36%
EPS beat(8)5
Avg EPS beat(8)2.5%
EPS beat(12)5
Avg EPS beat(12)-1.36%
EPS beat(16)7
Avg EPS beat(16)-2.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.53%
Min Revenue beat(2)-3.53%
Max Revenue beat(2)-1.54%
Revenue beat(4)1
Avg Revenue beat(4)-1.54%
Min Revenue beat(4)-3.53%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.11%
Revenue beat(12)3
Avg Revenue beat(12)-2.41%
Revenue beat(16)4
Avg Revenue beat(16)-2.23%
PT rev (1m)0.66%
PT rev (3m)5.55%
EPS NQ rev (1m)-0.18%
EPS NQ rev (3m)-6.41%
EPS NY rev (1m)-1.06%
EPS NY rev (3m)-1.71%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.77%
Revenue NY rev (1m)-1.27%
Revenue NY rev (3m)-1.58%
Valuation
Industry RankSector Rank
PE 30.68
Fwd PE 26.47
P/S 7.58
P/FCF 41.18
P/OCF 36.72
P/B 4.69
P/tB 14.49
EV/EBITDA 25
EPS(TTM)1.93
EY3.26%
EPS(NY)2.24
Fwd EY3.78%
FCF(TTM)1.44
FCFY2.43%
OCF(TTM)1.61
OCFY2.72%
SpS7.81
BVpS12.62
TBVpS4.09
PEG (NY)6.44
PEG (5Y)2.73
Graham Number23.41
Profitability
Industry RankSector Rank
ROA 3.04%
ROE 3.91%
ROCE 11.3%
ROIC 9.33%
ROICexc 9.93%
ROICexgc 24.48%
OM 22.13%
PM (TTM) 6.32%
GM 66.83%
FCFM 18.41%
ROA(3y)6.63%
ROA(5y)7.59%
ROE(3y)8.82%
ROE(5y)10.28%
ROIC(3y)9%
ROIC(5y)9.64%
ROICexc(3y)9.68%
ROICexc(5y)10.59%
ROICexgc(3y)24.93%
ROICexgc(5y)34.08%
ROCE(3y)10.9%
ROCE(5y)11.68%
ROICexgc growth 3Y-19.18%
ROICexgc growth 5Y-3.96%
ROICexc growth 3Y-9.13%
ROICexc growth 5Y5.53%
OM growth 3Y-6.91%
OM growth 5Y1.3%
PM growth 3Y-37.46%
PM growth 5Y-27.97%
GM growth 3Y-0.95%
GM growth 5Y0.33%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 1.34
Debt/EBITDA 0.8
Cap/Depr 25.63%
Cap/Sales 2.24%
Interest Coverage 14.5
Cash Conversion 66.94%
Profit Quality 291.58%
Current Ratio 4.22
Quick Ratio 2.81
Altman-Z 11.53
F-Score5
WACC10.79%
ROIC/WACC0.86
Cap/Depr(3y)40.04%
Cap/Depr(5y)43.01%
Cap/Sales(3y)3.78%
Cap/Sales(5y)4.03%
Profit Quality(3y)188.66%
Profit Quality(5y)177.71%
High Growth Momentum
Growth
EPS 1Y (TTM)7.82%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%0%
EPS Next Y4.76%
EPS Next 2Y7.66%
EPS Next 3Y10.98%
EPS Next 5Y8.61%
Revenue 1Y (TTM)-16%
Revenue growth 3Y3.33%
Revenue growth 5Y10.55%
Sales Q2Q%-1%
Revenue Next Year0.56%
Revenue Next 2Y3.76%
Revenue Next 3Y6.14%
Revenue Next 5Y7.1%
EBIT growth 1Y-10.6%
EBIT growth 3Y-3.81%
EBIT growth 5Y11.98%
EBIT Next Year15.61%
EBIT Next 3Y12.84%
EBIT Next 5Y8.56%
FCF growth 1Y3.97%
FCF growth 3Y-2.92%
FCF growth 5Y10.82%
OCF growth 1Y-2.5%
OCF growth 3Y-4.03%
OCF growth 5Y6.98%

BIO-TECHNE CORP / TECH FAQ

Can you provide the ChartMill fundamental rating for BIO-TECHNE CORP?

ChartMill assigns a fundamental rating of 6 / 10 to TECH.


What is the valuation status for TECH stock?

ChartMill assigns a valuation rating of 4 / 10 to BIO-TECHNE CORP (TECH). This can be considered as Fairly Valued.


How profitable is BIO-TECHNE CORP (TECH) stock?

BIO-TECHNE CORP (TECH) has a profitability rating of 7 / 10.


How financially healthy is BIO-TECHNE CORP?

The financial health rating of BIO-TECHNE CORP (TECH) is 7 / 10.


What is the expected EPS growth for BIO-TECHNE CORP (TECH) stock?

The Earnings per Share (EPS) of BIO-TECHNE CORP (TECH) is expected to grow by 4.76% in the next year.